ELCO Management’s United Therapeutics UTHR Stock Holding History

ELCO Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Sell	400 -6	-1%	-$3.38K	0.09%	161
2026 Q1	$241K	Buy	+406	New	+$202K	0.12%	144
2025 Q1	–	Sell	-669	Closed	-$236K	–	164
2024 Q4	$236K	Sell	669 -8	-1%	-$2.94K	0.12%	139
2024 Q3	$243K	Sell	677 -53	-7%	-$17.9K	0.13%	139
2024 Q2	$233K	Sell	730 -181	-20%	-$47.9K	0.14%	131
2024 Q1	$209K	Buy	+911	New	+$206K	0.13%	138

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

ELCO Management's UTHR Position: Q2 2026 in Review

ELCO Management reduced its United Therapeutics (UTHR) stake by 1.5% in Q2 2026, selling an estimated $3.38K and leaving 400 shares worth $217K. The position accounts for 0.09% of the portfolio, ranked #161.

ELCO Management first reported a position in UTHR in Q1 2024 and has held it in 6 quarters since. The position peaked at $243K in Q3 2024. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

ELCO Management held 400 shares of United Therapeutics worth $217K as of Q2 2026.
ELCO Management sold 6 United Therapeutics shares in Q2 2026, an estimated $3.38K.
United Therapeutics made up 0.09% of ELCO Management's portfolio in Q2 2026, its #161 holding.
ELCO Management first reported a position in United Therapeutics in Q1 2024 and has held it in 6 quarters since.
ELCO Management's United Therapeutics position peaked at $243K in Q3 2024.
881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on ELCO Management's 13F filing for Q2 2026, filed 11 Aug 2026.